The BRCA1 c. 5096G> A p. Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management …
S Moghadasi, HD Meeks, MPG Vreeswijk… - Journal of medical …, 2018 - jmg.bmj.com
Background We previously showed that the BRCA1 variant c. 5096G> A p. Arg1699Gln
(R1699Q) was associated with an intermediate risk of breast cancer (BC) and ovarian …
(R1699Q) was associated with an intermediate risk of breast cancer (BC) and ovarian …